WHC is still in active development. Read this to understand our approach.
depiction of FYOWWXMGDATDQY-UHFFFAOYSA-N.svg
tripsit

rolicyclidine

Check on tripsit

isomerdesign

PCPy

Check on isomerdesign

pubchem

Rolicyclidine

Check on pubchem

drugmap

Rolicyclidine

Check on drugmap

wiki

Rolicyclidine

Check on wiki

Data

InChI: InChI=1S/C16H23N/c1-3-9-15(10-4-1)16(11-5-2-6-12-16)17-13-7-8-14-17/h1,3-4,9-10H,2,5-8,11-14H2

Synonyms: DSSTox_RID_81398,UNII-183O9O9JE3, DSSTox_CID_26167,Rolicyclidinum [INN-Latin],Rolicyclidine [INN], Roliciclidina [INN-Spanish], Roliciclidina,CHEMBL1719398, DTXSID8046167, NCGC00160464-01,183O9O9JE3,Q570183, CHEMBL1719398,CAS-2201-39-0,1-(1-phenylcyclohexyl)-pyrrolidine,Rolicyclidinum, Rolicyclidinum,1-(1-Phenylcyclohexyl)pyrrolidine,Roliciclidina,DEA No. 7458,Pyrrolidine analog of phencyclidine,PCPy, 1-(1-Phenylcyclohexyl)pyrrolidine,Pyrrolidine, 1-(1-phenylcyclohexyl)-, AC1L1X48,Roliciclidina [INN-Spanish],ROLICYCLIDINE, DSSTox_GSID_46167,SCHEMBL517928, SCHEMBL517928,Pyrrolidine, 1-(1-phenylcyclohexyl), HSDB 7636, CHEBI:60805,NCGC00160464-01,CHEBI:60805, Rolicyclidine [INN],PCP pyrrolidine analog, Pyrrolidine analog of phencyclidine, FYOWWXMGDATDQY-UHFFFAOYSA-N,2201-39-0,DB01549, Rolicyclidinum [INN-Latin], 1-(1-phenylcyclohexyl)-pyrrolidine, DEA No. 7458, PCP pyrrolidine analog, UNII-183O9O9JE3,pcpy,ROLICYCLIDINE [HSDB],DTXSID8046167,ZINC1481918, Pyrrolidine, 1-(1-phenylcyclohexyl)-, PCPy,Rolicyclidine,HSDB 7636,DSSTox_CID_26167,Tox21_111832,DSSTox_GSID_46167, DSSTox_RID_81398, 183O9O9JE3, 2201-39-0,1-(1-phenylcyclohexyl)pyrrolidine (Rolicyclidine)

Estimated data

Solubility: -3.038 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 90.0% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.